Exploring the structural insights on human laforin mutation K87A in Lafora disease--a molecular dynamics study

Area of Science:

• Neurogenetics
• Molecular Biology
• Structural Biology

Background:

• Lafora disease (LD) is an autosomal recessive, progressive myoclonus epilepsy with a global prevalence.
• Onset typically occurs in adolescence, leading to rapid decline and death within 2-10 years.
• Mutations in EPM2A and EPM2B genes account for 90% of LD cases, with EPM2A encoding the laforin protein.

Purpose of the Study:

• To investigate the structural insights of laforin mutation K87A using molecular dynamics (MD) simulations.
• To understand the molecular basis of laforin's function and how mutations affect its interaction with glycogen.

Main Methods:

• Performed molecular dynamics (MD) simulations on both native and K87A mutant laforin protein.
• Analyzed structural changes using root mean square deviation (RMSD), root mean square fluctuation (RMSF), solvent accessibility surface area (SASA), radius of gyration (Rg), hydrogen bonds, and principal component analysis (PCA).

Main Results:

• MD simulations demonstrated a loss of stability in the K87A mutant laforin structure.
• Conformational changes in the mutant protein were confirmed through various analytical methods.
• The K87A mutation, involving an amino acid substitution in the carbohydrate-binding module (CBM), significantly impacts glycogen binding.

Conclusions:

• The K87A mutation in laforin leads to increased structural flexibility and abolished glycogen binding, providing a structural explanation for Lafora disease pathogenesis.
• Understanding these structural dynamics is crucial for developing therapeutic strategies for Lafora disease.